Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDEAL-2: Calcitriol in Diabetic Nephropathy
NCT03216564Phase 3Unknown
- Sponsor
- Hamad Medical Corporation
- Start
- May 2017
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of calcitriol in diabetic nephropathy (DN), sponsored by Hamad Medical Corporation. Status: unknown.
02
Drugs
calcitriol
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT03216564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03216564.